Martin’s biotech fund to inject €39m into US drug company

Martin’s biotech fund to inject €39m into US drug company

Malin, the Irish biotech investment fund backed by former Elan boss Kelly Martin, will pump €39 million into an American drug company.

Malin, which intends to list on the Irish stock exchange later this month, has agreed to pay $18 million (€16.5 million) for an initial 41 per cent in Serenus Biotherapeutics. Depending on how Serenus performs, Malin will raise its shareholding in the company to 76 per cent for an additional $25 million.

Please Subscribe or Log in to continue reading

Subscribe Login

Independent journalism every day

With digital access you can read The Business Post whenever, wherever, and however you want.

  • Unlimited access to all sections of The Business Post on desktop, tablet and mobile.
  • Breaking news, comment and analysis from the best Business Post writers seven days a week.
  • Live blogs of major news events
  • Videos and podcasts from some of the industry's most respected journalists such as Tom Lyons, Susan Mitchell and Ian Guider
  • Access to The Business Post's extensive archive​

Related Articles

More from The Business Post